Vaping exposes you to significantly fewer toxic chemicals than smoking cigarettes, but it is not harmless. Exclusive e-cigarette users show 10% to 98% lower levels of cancer-causing compounds and other toxicants in their bodies compared to cigarette smokers. That’s a meaningful difference, though “less harmful” is not the same as “safe,” and the long-term effects of vaping are still not fully understood.
What You’re Actually Inhaling
Cigarette smoke is produced by burning tobacco, a process called combustion. That burning generates more than 7,000 chemicals, including dozens of known carcinogens. E-cigarettes heat a liquid into an aerosol without combustion, which eliminates most of those byproducts.
The difference shows up clearly in blood and urine tests. A large study published in JAMA Network Open compared biomarkers in exclusive vapers and exclusive smokers. Levels of NNAL, a breakdown product of one of the most potent cancer-causing chemicals in tobacco, were roughly 98% lower in e-cigarette users. Acrolein, a compound that damages the lungs and cardiovascular system, was about 60% lower. Across a range of toxic volatile chemicals and cancer-linked compounds, vapers consistently had far less exposure than smokers.
That said, e-cigarettes are not emission-free. The aerosol contains nicotine, fine particles, and can include small amounts of heavy metals like nickel and lead that leach from the heating coil. One analysis of pod-type devices found nickel levels up to 373 nanograms per 10 puffs and lead up to 463 nanograms per 10 puffs, though concentrations vary widely between devices. Later-generation devices with higher power settings can also produce more irritating compounds like formaldehyde and acetaldehyde.
Effects on Your Lungs
Cigarette smoke causes more direct damage to lung tissue than e-cigarette aerosol. In studies using samples taken directly from the airways, vapers showed levels of inflammation that fell between those of smokers and people who have never smoked. Cigarette smoke triggered more cell death and stronger inflammatory signals overall.
However, vaping does affect the lungs in ways that are distinct from smoking, not simply a milder version of the same thing. Research on airway fluid found that both e-cigarette aerosol and cigarette smoke caused similar levels of dehydration in the cells lining the airways, even though smoke caused more inflammation and tissue injury. This means vaping carries its own set of respiratory effects that researchers are still working to characterize. For someone switching from cigarettes, lung function generally improves, but vaping is not the same as breathing clean air.
Heart and Blood Vessel Effects
Both cigarettes and e-cigarettes affect your cardiovascular system in the short term. A single session of either smoking or vaping causes a temporary increase in arterial stiffness, a measure of how hard your heart has to work to push blood through your vessels. One study found comparable spikes in arterial stiffness after both tobacco cigarettes and e-cigarettes, though another study in women found a significant increase only after smoking, not after vaping.
The more encouraging finding comes from people who switch entirely. Healthy smokers who replaced cigarettes with e-cigarettes showed meaningful improvement in blood vessel function and arterial stiffness within one month. Blood pressure and heart rate did not change significantly, but the vessels themselves became more flexible and responsive. This suggests that for current smokers, switching fully to vaping takes some cardiovascular strain off the body relatively quickly.
The “95% Safer” Claim
You may have seen the figure that e-cigarettes are “at least 95% less harmful than smoking.” This originated from a 2015 report commissioned by Public Health England, and it has been repeated in official health campaigns across the UK. A follow-up review in 2018 reaffirmed the estimate as a useful way to communicate the large gap in risk between vaping and smoking.
The number is not universally accepted, though. Several prominent researchers have published critiques calling the estimate poorly supported, noting it was based on limited data and a panel process rather than comprehensive toxicological analysis. The figure also does not account for the fact that risk reduction varies by disease. The reduction in cancer risk from switching may be very different from the reduction in cardiovascular risk or the risk of nicotine addiction. It is best understood as a rough communication tool rather than a precise scientific measurement.
Vaping as a Quit-Smoking Tool
For smokers trying to quit, e-cigarettes have outperformed traditional nicotine replacement products like patches and gum in at least one major clinical trial. A UK study that randomized smokers to either e-cigarettes or standard nicotine replacement therapy, both with behavioral support, found that 18% of the e-cigarette group remained smoke-free at one year, compared to 10% in the nicotine replacement group. At the six-month mark, the gap was similar: 21% versus 12%.
These are modest numbers either way, which reflects how difficult quitting nicotine is. But the roughly doubled success rate is meaningful. The catch is that many people in the e-cigarette group were still vaping at the end of the trial, meaning they had traded one nicotine delivery system for a less harmful one rather than becoming completely nicotine-free. Whether that trade-off is a success depends on your perspective.
Why Dual Use Doesn’t Help Much
If you’re thinking about vaping alongside smoking rather than switching completely, the benefits largely disappear. Studies tracking people who both vape and smoke found that their toxicant exposure levels are comparable to those of exclusive smokers. The reason is straightforward: even a few cigarettes a day deliver enough combustion byproducts to keep your exposure high. The harm from cigarettes does not scale down proportionally with each one you eliminate.
There is one exception. When dual users vape frequently and smoke only occasionally, perhaps a few cigarettes per week rather than per day, measurable reductions in cancer-linked compounds and carbon monoxide do appear. The pattern matters: predominantly vaping with rare smoking is meaningfully different from predominantly smoking with occasional vaping. If you are using a vape to cut down, the goal should be to get cigarette use as close to zero as possible.
What the FDA Has Actually Authorized
In the United States, the FDA has authorized 41 specific e-cigarette products for sale, all in tobacco or menthol flavors. These include products from JUUL, Vuse, NJOY, Logic, and one from a smaller manufacturer called Glas. Authorization means the FDA determined these particular products are “appropriate for the protection of public health,” largely because they can help adult smokers move away from cigarettes without attracting significant youth uptake.
Authorization is not an endorsement of safety. The FDA explicitly states that all tobacco products, including authorized e-cigarettes, are harmful and potentially addictive. The thousands of flavored, unregulated, or counterfeit vapes sold online and in stores have not gone through this review process, and their contents are far less predictable. If you are choosing a vape as a harm-reduction tool, sticking with an FDA-authorized product gives you a baseline level of manufacturing oversight that unregulated products lack.
The Bottom Line on Relative Harm
For a current smoker, switching completely to an e-cigarette reduces exposure to cancer-causing chemicals, eases some cardiovascular strain, and lowers airway inflammation. The reduction in toxic exposure is large and well-documented. For someone who does not currently smoke or use nicotine, picking up a vape introduces nicotine addiction and exposes the lungs to fine particles, metals, and other compounds with unknown long-term consequences. Vaping is substantially less dangerous than smoking. It is not risk-free, and it is not a good idea for anyone who is not already hooked on nicotine.